The WU-CDTR compiles and regularly updates a list of potential funding opportunities related to obesity, diabetes, and translational research.

In addition, the Washington University Office of the Vice Chancellor of Research maintains a comprehensive database of both internal and external funding resources. 

Information on the WU-CDTR pilot and feasibility program can be found here.

Source/FAOTitleDue DateSponsor Name
PAR-19-274Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)None PostedNational Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
 Educational Program GrantsNone PostedDiabetes Research and Wellness Foundation (U.S.)
RFA-DK-19-504
RFA-DK-19-504–Limited Competition: Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CPDPC-CDMC) (U01 Clinical Trial Optional) (Defunct)
None postedNational Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-20-015RFA-DK-20-015 — Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional) (Defunct)None postedNational Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
 Systems and Best Practices Grants02-Apr-2021Tufts Health Plan Foundation
PAR-19 -379Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)08-Apr-2021National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-20-025RFA-DK-20-025 — Diabetes Research Centers (P30 Clinical Trial Optional)20-Apr-2021National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-AI-20-078RFA-AI-20-078 — Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)05-May-2021National Institute of Allergy and Infectious Diseases/NIH/DHHS
RFA-OD-20-016RFA-OD-20-016 — Emergency Awards: RADx-RAD Multimodal COVID-19 Surveillance Methods for High Risk Clustered Populations (R01 Clinical Trial Optional)07-May-2021National Institutes of Health/DHHS
RFA-DK-20-032RFA-DK-20-032 — Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)22-May-2021National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-19-004RFA-DK-19-004 — Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)01-Jun-2021National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
NOT-DK-21-013Notice of NIDDK Participation in PAR-19-274, “Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)”05- Jun- 2021National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-CA-20-028RFA-CA-20-028 — Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)30-Jun-2021National Cancer Institute/NIH/DHHS
RFA-OD-19-029RFA-OD-19-029 — The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)26-Oct-2021Office of Research on Women’s Health/NIH/DHHS
RFA-OD-20-003RFA-OD-20-003 — Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)04-Oct-2021National Institutes of Health/DHHS

Last Updated March 30th, 2021